Skip to main content
. 2018 May 22;2(8):903–921. doi: 10.1210/js.2018-00024

Figure 2.

Figure 2.

Acute effects of oxybenzone on ER-mediated endpoints in vivo. (A) Unlike acute exposure to 17β-estradiol, acute exposure to 3000 µg oxybenzone/kg/d did not induce an increase in uterine weight. (B) Acute exposure to 17β-estradiol or oxybenzone increased expression of ERα (Esr1) in the uterus. Different letters indicate significant differences among groups, P < 0.05, Fisher LSD post hoc after significant ANOVA.